(Q36194741)

12 August 2017

1 reference

title

Glucocorticoid receptor function in vitro in patients with major depression (English)

1 reference

12 August 2017

Carmine M Pariante

1

0 references

language of work or name

1 reference

1 December 2004

1 reference

12 August 2017

1 reference

12 August 2017

7

1 reference

12 August 2017

4

1 reference

12 August 2017

209-219

1 reference

Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression.

12 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Altered glucocorticoid immunoregulation in treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Rapid reversal of psychotic depression using mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Effects of glucocorticoids on declarative memory function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Preservation of hypothalamic-pituitary-adrenal axis fast-feedback responses in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Stress and the progression of the developmental hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Vasoconstrictor response to topical beclomethasone in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Regulation of adult neurogenesis by antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Lymphocyte glucocorticoid receptor binding in depression: normal values following recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Future therapeutic targets in mood disorders: the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Real-time imaging of glucocorticoid receptor dynamics in living neurons and glial cells in comparison with non-neural cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Depression, Stress and the Adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Do antidepressants regulate how cortisol affects the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Depression in cancer: new developments regarding diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Lymphocyte glucocorticoid receptor binding in depressed patients with hypercortisolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Mechanisms of glucocorticoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Mononuclear leukocyte glucocorticoid receptor binding characteristics and down-regulation in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Inhibition of P-glycoprotein by newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Relationship between dexamethasone-inhibited lysozyme activity in peripheral mononuclear leukocytes and the cortisol and glucocorticoid receptor response to dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Loss of Glucocorticoid Fast Feedback in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Mineralocorticoid receptor function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

Pituitary volume in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890500069650

10.1080/10253890500069650

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16019586